High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center

Samuel L. Aitken; Jeffrey J. Tarrand; Lalitagauri M. Deshpande; Frank P. Tverdek; Anne L. Jones; Samuel A. Shelburne; Randall A. Prince; Micah M. Bhatti; Kenneth V.I. Rolston; Ronald N. Jones; Mariana Castanheira; Roy F. Chemaly

doi:10.1093/cid/ciw398

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center

Samuel L. Aitken, Jeffrey J. Tarrand, Lalitagauri M. Deshpande, Frank P. Tverdek, Anne L. Jones, Samuel A. Shelburne, Randall A. Prince, Micah M. Bhatti, Kenneth V.I. Rolston, Ronald N. Jones, Mariana Castanheira, Roy F. Chemaly

Research output: Contribution to journal › Article

30 Scopus citations

Abstract

Resistance to the novel β-lactam/β-lactamase inhibitor combination ceftazidime-avibactam (CAZ-AVI) among carbapenem-resistant Enterobacteriaceae (CRE) has infrequently been reported in the United States. We report unexpectedly high rates of resistance to CAZ-AVI in CRE bloodstream isolates at our institution associated with the nonoutbreak spread of New Delhi metallo-β-lactamase in diverse Enterobacteriaceae species.

Original language	English (US)
Pages (from-to)	954-958
Number of pages	5
Journal	Clinical Infectious Diseases
Volume	63
Issue number	7
DOIs	https://doi.org/10.1093/cid/ciw398
State	Published - Oct 1 2016

Keywords

CRE
NDM
bacteremia
carbapenemase
ceftazidime-avibactam

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciw398

Fingerprint Dive into the research topics of 'High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center'. Together they form a unique fingerprint.

Cite this

Aitken, S. L., Tarrand, J. J., Deshpande, L. M., Tverdek, F. P., Jones, A. L., Shelburne, S. A., Prince, R. A., Bhatti, M. M., Rolston, K. V. I., Jones, R. N., Castanheira, M., & Chemaly, R. F. (2016). High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. Clinical Infectious Diseases, 63(7), 954-958. https://doi.org/10.1093/cid/ciw398

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. / Aitken, Samuel L.; Tarrand, Jeffrey J.; Deshpande, Lalitagauri M.; Tverdek, Frank P.; Jones, Anne L.; Shelburne, Samuel A.; Prince, Randall A.; Bhatti, Micah M.; Rolston, Kenneth V.I.; Jones, Ronald N.; Castanheira, Mariana; Chemaly, Roy F.

In: Clinical Infectious Diseases, Vol. 63, No. 7, 01.10.2016, p. 954-958.

Research output: Contribution to journal › Article

Aitken, SL, Tarrand, JJ, Deshpande, LM, Tverdek, FP, Jones, AL, Shelburne, SA, Prince, RA, Bhatti, MM, Rolston, KVI, Jones, RN, Castanheira, M & Chemaly, RF 2016, 'High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center', Clinical Infectious Diseases, vol. 63, no. 7, pp. 954-958. https://doi.org/10.1093/cid/ciw398

Aitken, Samuel L. ; Tarrand, Jeffrey J. ; Deshpande, Lalitagauri M. ; Tverdek, Frank P. ; Jones, Anne L. ; Shelburne, Samuel A. ; Prince, Randall A. ; Bhatti, Micah M. ; Rolston, Kenneth V.I. ; Jones, Ronald N. ; Castanheira, Mariana ; Chemaly, Roy F. / High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. In: Clinical Infectious Diseases. 2016 ; Vol. 63, No. 7. pp. 954-958.

@article{dbb8a210f7a94947ad86e87bd122db71,

title = "High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center",

abstract = "Resistance to the novel β-lactam/β-lactamase inhibitor combination ceftazidime-avibactam (CAZ-AVI) among carbapenem-resistant Enterobacteriaceae (CRE) has infrequently been reported in the United States. We report unexpectedly high rates of resistance to CAZ-AVI in CRE bloodstream isolates at our institution associated with the nonoutbreak spread of New Delhi metallo-β-lactamase in diverse Enterobacteriaceae species.",

keywords = "CRE, NDM, bacteremia, carbapenemase, ceftazidime-avibactam",

author = "Aitken, {Samuel L.} and Tarrand, {Jeffrey J.} and Deshpande, {Lalitagauri M.} and Tverdek, {Frank P.} and Jones, {Anne L.} and Shelburne, {Samuel A.} and Prince, {Randall A.} and Bhatti, {Micah M.} and Rolston, {Kenneth V.I.} and Jones, {Ronald N.} and Mariana Castanheira and Chemaly, {Roy F.}",

year = "2016",

month = oct,

day = "1",

doi = "10.1093/cid/ciw398",

language = "English (US)",

volume = "63",

pages = "954--958",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center

AU - Aitken, Samuel L.

AU - Tarrand, Jeffrey J.

AU - Deshpande, Lalitagauri M.

AU - Tverdek, Frank P.

AU - Jones, Anne L.

AU - Shelburne, Samuel A.

AU - Prince, Randall A.

AU - Bhatti, Micah M.

AU - Rolston, Kenneth V.I.

AU - Jones, Ronald N.

AU - Castanheira, Mariana

AU - Chemaly, Roy F.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Resistance to the novel β-lactam/β-lactamase inhibitor combination ceftazidime-avibactam (CAZ-AVI) among carbapenem-resistant Enterobacteriaceae (CRE) has infrequently been reported in the United States. We report unexpectedly high rates of resistance to CAZ-AVI in CRE bloodstream isolates at our institution associated with the nonoutbreak spread of New Delhi metallo-β-lactamase in diverse Enterobacteriaceae species.

AB - Resistance to the novel β-lactam/β-lactamase inhibitor combination ceftazidime-avibactam (CAZ-AVI) among carbapenem-resistant Enterobacteriaceae (CRE) has infrequently been reported in the United States. We report unexpectedly high rates of resistance to CAZ-AVI in CRE bloodstream isolates at our institution associated with the nonoutbreak spread of New Delhi metallo-β-lactamase in diverse Enterobacteriaceae species.

KW - CRE

KW - NDM

KW - bacteremia

KW - carbapenemase

KW - ceftazidime-avibactam

UR - http://www.scopus.com/inward/record.url?scp=84990966427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990966427&partnerID=8YFLogxK

U2 - 10.1093/cid/ciw398

DO - 10.1093/cid/ciw398

M3 - Article

AN - SCOPUS:84990966427

VL - 63

SP - 954

EP - 958

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 7

ER -